SlideShare a Scribd company logo
1 of 24
Download to read offline
www.bharatbiotech.com
Corporate Profile 2014
www.bharatbiotech.com
Fast Facts
Issues
Products
R&D Pipeline
Projects
Recognition
Executive Summary
www.bharatbiotech.com
Fast Facts
www.bharatbiotech.com
Fast Facts Issues Products R&D Pipeline Projects Recognition
Established : 1996
Promoters : Dr. Krishna & Ms. Suchitra Ella
Business Line : Vaccines and Bio-therapeutics
First Project : Hepatitis B Vaccine - US $ 3.5 Mn
Investment : Over US $ 150 Mn till date
Facility : One of the largest facilities in Asia
Personnel : 700 resources including scientists
Accreditations : Korean FDA, ANVISA, other Countries
Innovation : 50 Global patents
Vision
Mission
To offer affordable, safe
and effective healthcare
solutions to combat mankind's
most dreaded illnesses, and to
thus eradicate or at least control
their occurrence in the years to
come.
Developing next-generation
remedies through Genetic
Engineering Technologies so as to
create a healthier world.
Mission 7 Billion
www.bharatbiotech.com
Issues
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Emerging Country Challenges
Lack of clarity on disease burden, public health focus & policies
NEGLECTEDAPPROACH
NEGLECTEDDISEASES
1 TYPHOID
2 HEPATITIS
3 ROTA
4 SCHISTOSOMIASIS
5 E. COLI
6 CHOLERA
7 OTHER DIARRHEA
1 JE
2 DENGUE
3 CHIKUNGUNYA
4 MALARIA
5 TRYPANOSOMA
6 LEISHMANIA
7 FILARIA
POLITICAL
COMMITTMENT
SCIENTIFIC
COMMITTMENT
Fast Facts Issues
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Thinking Future
Today’s neglected diseases - Tomorrow’s global diseases
1 PLAGUE
2 HIV
3 INFLUENZA
4 MALARIA
1 DENGUE
2 CHIKUNGUNYA
3 TRYPANOSOMA
4 LEISHMANIA
5 FILARIA
6 JAPANESE ENCEPHALITIS
Fast Facts Issues
• No DW manufactures develop new vaccines.
• Most DW manufactures are biogeneric players.
• DC manufactures follow MNCs.
• Our Mission is to change that mindset.
NEGLECTED DISEASES
GLOBAL DISEASES
www.bharatbiotech.com
Emerging Market Value Proposition
Bharat Biotech Strategy
Population
Birth Cohort
Health Care Budgets
Increasing
Health Care Budgets
Decreasing
Our growth path for
future is here
Emerging
6 Billion
125 Million
Low Value
High Volume
Products R&D Pipeline Projects RecognitionFast Facts Issues
Developed
0.75 Billion
7.5 Million
High Value
Low Volume
www.bharatbiotech.com
Products
www.bharatbiotech.com
JE Launch
The Union Health & Family Welfare Minister, Shri Ghulam Nabi Azad launching
Japanese Encephalitis vaccine on 04th October, 2013 in New Delhi
Products R&D Pipeline Projects RecognitionIssuesFast Facts
Purified, Inactivated Japanese Encephalitis Vaccine
1st indigenously developed
www.bharatbiotech.com
TCV Launch
Products R&D Pipeline Projects RecognitionIssuesFast Facts
Vi Capsular Polysaccharide Tetanus Toxoid Conjugate Vaccine
World’s 1st Clinically Proven Typhoid Conjugate Vaccine
Dr. Christian Loucq - International Vaccine Institute Director-General launching
Typhoid Conjugate Vaccine in Hyderabad on 26th August, 2013
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Product Launches
Dr. A.P.J. Abdul Kalam
Former President of India, launching
Dr. John Robbins
Father of Polysaccharide Vaccine
National Institute of Health, USA, launching
Dr. Julie Gerberding
Former Director of the U.S. Centers for
Disease Control, launching
IssuesFast Facts
www.bharatbiotech.com
Vaccines
Wide Product Portfolio
S. No. Vaccine Brand
1 DPT+ Hep B + Hib Comvac 5 ®
2 DPT+ Hep B Comvac 4-Hb ®
3 DPT; TT, DT Comvac 3 ™
4 Hep B Revac B+ ®
5 Hep B Revac B mcf ®
6 Hib BioHib ™
7 Typhoid Typbar ®
8 Typhoid Typbar TCV ™
9 OPV Trivalent BIOPOLIO ®
10 OPV Monovalent Type-1 BIOPOLIO M1 ™
11 OPV Monovalent Type-3 BIOPOLIO M3 ™
12 OPV Bivalent BIOPOLIO B1/3 ™
13 JE Jenvac ®
Products R&D Pipeline Projects RecognitionIssuesFast Facts
S. No. Vaccine Brand
1 Typhoid Typbar ®
2 Typhoid Typbar TCV ™
3 Rabies INDIRAB ®
4 Influenza HN VAC ™
5 JE Jenvac ®
S. No. Vaccine Brand
1 Typhoid Typbar ®
2 Typhoid Typbar TCV ™
3 Influenza HN VAC ™
4 JE Jenvac ®
Children & Adult
Traveler
Children
www.bharatbiotech.com
Bio-therapeutics
Wide Product Portfolio
Products R&D Pipeline Projects RecognitionIssuesFast Facts
S. No. Bio-therapeutic Brand
1 Probiotic Yeast BIOGIT™
2
Recombinant Human Epidermal
Growth Factor
REGEN-D ®
3
Recombinant Human Epidermal
Growth Factor, Silver Sulfadiazine &
Chlorexidine Gluconate Cream
SLVRGEN ®
4 Zinc with ORS ZELECT ®
www.bharatbiotech.com
Product Distribution
More than 2 Billion doses delivered
Products R&D Pipeline Projects RecognitionIssuesFast Facts
www.bharatbiotech.com
More than 2 Billion doses delivered
Products R&D Pipeline Projects RecognitionIssuesFast Facts
Korea
Nepal
Philippines
Brazil
(ANVISA)
Sri Lanka
Saudi
Arabia
Colombia
(INVIMA)
Ghana
KenyaCongo
Turkey
Kazakhstan
Uganda
Syria
Malawi
Ukraine
Belarus
Ivory Coast
Accreditation
Pakistan
Myanmar
www.bharatbiotech.com
R&D Pipeline
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Pipeline Products
1st Time in the world Typhoid Conjugate Vaccine
S. No. Vaccines Product
Development
Preclinical
Testing Phase I Phase II Phase III Commercial
License
1 Chikungunya 2017
2 Malaria PvRII 2017
3 Staph Aureus MRSA 2018
4 Human Papilloma Virus 2018
5 Acellular Pertussis 2016
6 Tetanus (Meat Free) 2016
7 S. Paratyphi 2018
8 NTS Conjugates 2018
9 Sabin IPV 2018
Therapeutics Product
Development
Preclinical
Testing Phase I Phase II Phase III Commercial
License
1 THR-100 2015
2 Lysostaphin Topical 2015
3 Lysostaphin IV 2017
4 r Human Serum Albumin 2014
IssuesFast Facts
www.bharatbiotech.com
Projects
www.bharatbiotech.com
Recognition
www.bharatbiotech.com
Recognition of Achievements
Young Enterprising Company
Products R&D Pipeline Projects RecognitionIssuesFast Facts
VOA awards 2013
most promising vaccines for paediatric
16th March, 2013
Pharma Bio World Award
Business Leader of the Year
Biotechnology 2011
Best R&D Company of the year 2010
by Pharmaceutical Leadership Summit
2010 Mumbai
National Technology
Award Govt of India 2006
Business Innovation Marico Foundation
& Business World 2006
www.bharatbiotech.com
Recognition of Achievements
Young Enterprising Company
Products R&D Pipeline Projects RecognitionIssuesFast Facts
JRD TATA Best Entrepreneur award FICCI Award Excellence in Science
Best Performance in Technology
Marico Foundation Innovation Award
TDB National award DBT-award for Product & Process
www.bharatbiotech.com
“Our mission is to address the health care needs of emerging markets,
drive innovation, be a front runner in research and development of
new vaccines and bio-therapeutics”
Mission 7 Billion
Dr. Krishna M. Ella
Chairman & Managing Director
www.bharatbiotech.com
Thank You
Address
Products R&D Pipeline Projects RecognitionIssuesFast Facts
Bharat Biotech International Limited
Genome Valley, Shameerpet Mandal,
Ranga Reddy District - 500 078 Andhra Pradesh, India.
Tel.: +91 40 2348 0567
Fax: +91 40 2348 0560
info@bharatbiotech.com
www.bharatbiotech.com

More Related Content

What's hot

Tim Wallis, Founder and Managing Director, Ridgeway Biologicals Ltd
Tim Wallis, Founder and Managing Director, Ridgeway Biologicals LtdTim Wallis, Founder and Managing Director, Ridgeway Biologicals Ltd
Tim Wallis, Founder and Managing Director, Ridgeway Biologicals LtdKisaco Research
 
Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...
Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...
Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...Kisaco Research
 
Mark Engel, CEO, Phagelux
Mark Engel, CEO, PhageluxMark Engel, CEO, Phagelux
Mark Engel, CEO, PhageluxKisaco Research
 
Dr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co Ltd
Dr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co LtdDr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co Ltd
Dr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co LtdKisaco Research
 
ATCC Zika Virus Research Materials Flyer
ATCC Zika Virus Research Materials FlyerATCC Zika Virus Research Materials Flyer
ATCC Zika Virus Research Materials FlyerATCC
 
What You May Have Missed at AACC 2018 White Paper - Kalorama Information
What You May Have Missed at AACC 2018 White Paper - Kalorama InformationWhat You May Have Missed at AACC 2018 White Paper - Kalorama Information
What You May Have Missed at AACC 2018 White Paper - Kalorama InformationBruce Carlson
 
Nucleotide-Based Diagnostic for Infectious Diseases
Nucleotide-Based Diagnostic for Infectious DiseasesNucleotide-Based Diagnostic for Infectious Diseases
Nucleotide-Based Diagnostic for Infectious Diseaseskphodel
 
Bus Forum Preso Bio 2009 Ec6
Bus Forum Preso Bio 2009 Ec6Bus Forum Preso Bio 2009 Ec6
Bus Forum Preso Bio 2009 Ec6guest93170a
 
Ways Forward – Vaccine Manufacturing Tomorrow
Ways Forward – Vaccine Manufacturing TomorrowWays Forward – Vaccine Manufacturing Tomorrow
Ways Forward – Vaccine Manufacturing TomorrowMerck Life Sciences
 
Webinar: Re-imagining vaccine manufacturing to address global health challenges
Webinar: Re-imagining vaccine manufacturing to address global health challengesWebinar: Re-imagining vaccine manufacturing to address global health challenges
Webinar: Re-imagining vaccine manufacturing to address global health challengesMilliporeSigma
 

What's hot (15)

Tim Wallis, Founder and Managing Director, Ridgeway Biologicals Ltd
Tim Wallis, Founder and Managing Director, Ridgeway Biologicals LtdTim Wallis, Founder and Managing Director, Ridgeway Biologicals Ltd
Tim Wallis, Founder and Managing Director, Ridgeway Biologicals Ltd
 
Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...
Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...
Prof. Zhao Yarong, General Manager of Animal Medicine Research Center of Da B...
 
Globavir Presentation - Apri 2018
Globavir Presentation - Apri 2018Globavir Presentation - Apri 2018
Globavir Presentation - Apri 2018
 
Mark Engel, CEO, Phagelux
Mark Engel, CEO, PhageluxMark Engel, CEO, Phagelux
Mark Engel, CEO, Phagelux
 
darpa documents
darpa documentsdarpa documents
darpa documents
 
Dr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co Ltd
Dr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co LtdDr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co Ltd
Dr Schucheng Zhang, Vice President, Sinovet (Beijing) Biotechnology Co Ltd
 
ATCC Zika Virus Research Materials Flyer
ATCC Zika Virus Research Materials FlyerATCC Zika Virus Research Materials Flyer
ATCC Zika Virus Research Materials Flyer
 
What You May Have Missed at AACC 2018 White Paper - Kalorama Information
What You May Have Missed at AACC 2018 White Paper - Kalorama InformationWhat You May Have Missed at AACC 2018 White Paper - Kalorama Information
What You May Have Missed at AACC 2018 White Paper - Kalorama Information
 
Nucleotide-Based Diagnostic for Infectious Diseases
Nucleotide-Based Diagnostic for Infectious DiseasesNucleotide-Based Diagnostic for Infectious Diseases
Nucleotide-Based Diagnostic for Infectious Diseases
 
CON4EI-general-vs2
CON4EI-general-vs2CON4EI-general-vs2
CON4EI-general-vs2
 
Globavir Presentation
Globavir PresentationGlobavir Presentation
Globavir Presentation
 
Srinivas ISTP India 2011
Srinivas ISTP India 2011Srinivas ISTP India 2011
Srinivas ISTP India 2011
 
Bus Forum Preso Bio 2009 Ec6
Bus Forum Preso Bio 2009 Ec6Bus Forum Preso Bio 2009 Ec6
Bus Forum Preso Bio 2009 Ec6
 
Ways Forward – Vaccine Manufacturing Tomorrow
Ways Forward – Vaccine Manufacturing TomorrowWays Forward – Vaccine Manufacturing Tomorrow
Ways Forward – Vaccine Manufacturing Tomorrow
 
Webinar: Re-imagining vaccine manufacturing to address global health challenges
Webinar: Re-imagining vaccine manufacturing to address global health challengesWebinar: Re-imagining vaccine manufacturing to address global health challenges
Webinar: Re-imagining vaccine manufacturing to address global health challenges
 

Similar to Bharat Biotech Corporate Profile and Product Pipeline

Lighting Rockets at the UChicago Microbiome Launchpad
Lighting Rockets at the UChicago Microbiome LaunchpadLighting Rockets at the UChicago Microbiome Launchpad
Lighting Rockets at the UChicago Microbiome LaunchpadLaura Berry
 
PEGS China 2015 Final Agenda
PEGS China 2015 Final AgendaPEGS China 2015 Final Agenda
PEGS China 2015 Final AgendaNicole Proulx
 
CVG - Medical Devices 2015
CVG - Medical Devices 2015CVG - Medical Devices 2015
CVG - Medical Devices 2015Paige Rasid
 
Seminor on fututre biotech
Seminor on fututre biotechSeminor on fututre biotech
Seminor on fututre biotechnirmalk1503
 
Seminor on fututre biotech
Seminor on fututre biotechSeminor on fututre biotech
Seminor on fututre biotechnirmalk1503
 
Nw biotech fundamentals day 1 session 1 20140612
Nw biotech fundamentals day 1 session 1 20140612Nw biotech fundamentals day 1 session 1 20140612
Nw biotech fundamentals day 1 session 1 20140612Nicholas Weston Lawyers
 
Deep Tech Startups vs Covid-19
Deep Tech Startups vs Covid-19Deep Tech Startups vs Covid-19
Deep Tech Startups vs Covid-19sosv
 
Skinomics crowdsmart
Skinomics crowdsmartSkinomics crowdsmart
Skinomics crowdsmartemmatayl
 
Covid 19 Vaccination SCM Analysis
Covid 19 Vaccination SCM AnalysisCovid 19 Vaccination SCM Analysis
Covid 19 Vaccination SCM AnalysisTejNarayanShaw2
 
Most emerging biotech companies to watch.pdf
Most emerging biotech companies to watch.pdfMost emerging biotech companies to watch.pdf
Most emerging biotech companies to watch.pdfInsightsSuccess4
 
Biotech business plan proposal
Biotech business plan proposalBiotech business plan proposal
Biotech business plan proposalMUMBAI UNIVERSITY
 
[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...
[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...
[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...500 Startups
 
Thomas Bigger, CEO, Curtiss Healthcare
Thomas Bigger, CEO, Curtiss HealthcareThomas Bigger, CEO, Curtiss Healthcare
Thomas Bigger, CEO, Curtiss HealthcareKisaco Research
 

Similar to Bharat Biotech Corporate Profile and Product Pipeline (20)

Lighting Rockets at the UChicago Microbiome Launchpad
Lighting Rockets at the UChicago Microbiome LaunchpadLighting Rockets at the UChicago Microbiome Launchpad
Lighting Rockets at the UChicago Microbiome Launchpad
 
PEGS China 2015 Final Agenda
PEGS China 2015 Final AgendaPEGS China 2015 Final Agenda
PEGS China 2015 Final Agenda
 
CVG - Medical Devices 2015
CVG - Medical Devices 2015CVG - Medical Devices 2015
CVG - Medical Devices 2015
 
Ranvver sharma ppt
Ranvver sharma pptRanvver sharma ppt
Ranvver sharma ppt
 
Seminor on fututre biotech
Seminor on fututre biotechSeminor on fututre biotech
Seminor on fututre biotech
 
Seminor on fututre biotech
Seminor on fututre biotechSeminor on fututre biotech
Seminor on fututre biotech
 
MRADUS16-PBCUS16_Agenda
MRADUS16-PBCUS16_AgendaMRADUS16-PBCUS16_Agenda
MRADUS16-PBCUS16_Agenda
 
PBIO Investor Presentation
PBIO Investor PresentationPBIO Investor Presentation
PBIO Investor Presentation
 
Probiotics
ProbioticsProbiotics
Probiotics
 
Nw biotech fundamentals day 1 session 1 20140612
Nw biotech fundamentals day 1 session 1 20140612Nw biotech fundamentals day 1 session 1 20140612
Nw biotech fundamentals day 1 session 1 20140612
 
Deep Tech Startups vs Covid-19
Deep Tech Startups vs Covid-19Deep Tech Startups vs Covid-19
Deep Tech Startups vs Covid-19
 
Skinomics crowdsmart
Skinomics crowdsmartSkinomics crowdsmart
Skinomics crowdsmart
 
Covid 19 Vaccination SCM Analysis
Covid 19 Vaccination SCM AnalysisCovid 19 Vaccination SCM Analysis
Covid 19 Vaccination SCM Analysis
 
Most emerging biotech companies to watch.pdf
Most emerging biotech companies to watch.pdfMost emerging biotech companies to watch.pdf
Most emerging biotech companies to watch.pdf
 
Biotech business plan proposal
Biotech business plan proposalBiotech business plan proposal
Biotech business plan proposal
 
Sinovac
SinovacSinovac
Sinovac
 
Biotech areas
Biotech areasBiotech areas
Biotech areas
 
[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...
[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...
[PreMoney SF 2015} SOS Ventures >> Sean O'Sullivan, "Accelerating Biology: Pr...
 
Thomas Bigger, CEO, Curtiss Healthcare
Thomas Bigger, CEO, Curtiss HealthcareThomas Bigger, CEO, Curtiss Healthcare
Thomas Bigger, CEO, Curtiss Healthcare
 
BSA_March_2015
BSA_March_2015BSA_March_2015
BSA_March_2015
 

Bharat Biotech Corporate Profile and Product Pipeline

  • 4. www.bharatbiotech.com Fast Facts Issues Products R&D Pipeline Projects Recognition Established : 1996 Promoters : Dr. Krishna & Ms. Suchitra Ella Business Line : Vaccines and Bio-therapeutics First Project : Hepatitis B Vaccine - US $ 3.5 Mn Investment : Over US $ 150 Mn till date Facility : One of the largest facilities in Asia Personnel : 700 resources including scientists Accreditations : Korean FDA, ANVISA, other Countries Innovation : 50 Global patents Vision Mission To offer affordable, safe and effective healthcare solutions to combat mankind's most dreaded illnesses, and to thus eradicate or at least control their occurrence in the years to come. Developing next-generation remedies through Genetic Engineering Technologies so as to create a healthier world. Mission 7 Billion
  • 6. www.bharatbiotech.com Products R&D Pipeline Projects Recognition Emerging Country Challenges Lack of clarity on disease burden, public health focus & policies NEGLECTEDAPPROACH NEGLECTEDDISEASES 1 TYPHOID 2 HEPATITIS 3 ROTA 4 SCHISTOSOMIASIS 5 E. COLI 6 CHOLERA 7 OTHER DIARRHEA 1 JE 2 DENGUE 3 CHIKUNGUNYA 4 MALARIA 5 TRYPANOSOMA 6 LEISHMANIA 7 FILARIA POLITICAL COMMITTMENT SCIENTIFIC COMMITTMENT Fast Facts Issues
  • 7. www.bharatbiotech.com Products R&D Pipeline Projects Recognition Thinking Future Today’s neglected diseases - Tomorrow’s global diseases 1 PLAGUE 2 HIV 3 INFLUENZA 4 MALARIA 1 DENGUE 2 CHIKUNGUNYA 3 TRYPANOSOMA 4 LEISHMANIA 5 FILARIA 6 JAPANESE ENCEPHALITIS Fast Facts Issues • No DW manufactures develop new vaccines. • Most DW manufactures are biogeneric players. • DC manufactures follow MNCs. • Our Mission is to change that mindset. NEGLECTED DISEASES GLOBAL DISEASES
  • 8. www.bharatbiotech.com Emerging Market Value Proposition Bharat Biotech Strategy Population Birth Cohort Health Care Budgets Increasing Health Care Budgets Decreasing Our growth path for future is here Emerging 6 Billion 125 Million Low Value High Volume Products R&D Pipeline Projects RecognitionFast Facts Issues Developed 0.75 Billion 7.5 Million High Value Low Volume
  • 10. www.bharatbiotech.com JE Launch The Union Health & Family Welfare Minister, Shri Ghulam Nabi Azad launching Japanese Encephalitis vaccine on 04th October, 2013 in New Delhi Products R&D Pipeline Projects RecognitionIssuesFast Facts Purified, Inactivated Japanese Encephalitis Vaccine 1st indigenously developed
  • 11. www.bharatbiotech.com TCV Launch Products R&D Pipeline Projects RecognitionIssuesFast Facts Vi Capsular Polysaccharide Tetanus Toxoid Conjugate Vaccine World’s 1st Clinically Proven Typhoid Conjugate Vaccine Dr. Christian Loucq - International Vaccine Institute Director-General launching Typhoid Conjugate Vaccine in Hyderabad on 26th August, 2013
  • 12. www.bharatbiotech.com Products R&D Pipeline Projects Recognition Product Launches Dr. A.P.J. Abdul Kalam Former President of India, launching Dr. John Robbins Father of Polysaccharide Vaccine National Institute of Health, USA, launching Dr. Julie Gerberding Former Director of the U.S. Centers for Disease Control, launching IssuesFast Facts
  • 13. www.bharatbiotech.com Vaccines Wide Product Portfolio S. No. Vaccine Brand 1 DPT+ Hep B + Hib Comvac 5 ® 2 DPT+ Hep B Comvac 4-Hb ® 3 DPT; TT, DT Comvac 3 ™ 4 Hep B Revac B+ ® 5 Hep B Revac B mcf ® 6 Hib BioHib ™ 7 Typhoid Typbar ® 8 Typhoid Typbar TCV ™ 9 OPV Trivalent BIOPOLIO ® 10 OPV Monovalent Type-1 BIOPOLIO M1 ™ 11 OPV Monovalent Type-3 BIOPOLIO M3 ™ 12 OPV Bivalent BIOPOLIO B1/3 ™ 13 JE Jenvac ® Products R&D Pipeline Projects RecognitionIssuesFast Facts S. No. Vaccine Brand 1 Typhoid Typbar ® 2 Typhoid Typbar TCV ™ 3 Rabies INDIRAB ® 4 Influenza HN VAC ™ 5 JE Jenvac ® S. No. Vaccine Brand 1 Typhoid Typbar ® 2 Typhoid Typbar TCV ™ 3 Influenza HN VAC ™ 4 JE Jenvac ® Children & Adult Traveler Children
  • 14. www.bharatbiotech.com Bio-therapeutics Wide Product Portfolio Products R&D Pipeline Projects RecognitionIssuesFast Facts S. No. Bio-therapeutic Brand 1 Probiotic Yeast BIOGIT™ 2 Recombinant Human Epidermal Growth Factor REGEN-D ® 3 Recombinant Human Epidermal Growth Factor, Silver Sulfadiazine & Chlorexidine Gluconate Cream SLVRGEN ® 4 Zinc with ORS ZELECT ®
  • 15. www.bharatbiotech.com Product Distribution More than 2 Billion doses delivered Products R&D Pipeline Projects RecognitionIssuesFast Facts
  • 16. www.bharatbiotech.com More than 2 Billion doses delivered Products R&D Pipeline Projects RecognitionIssuesFast Facts Korea Nepal Philippines Brazil (ANVISA) Sri Lanka Saudi Arabia Colombia (INVIMA) Ghana KenyaCongo Turkey Kazakhstan Uganda Syria Malawi Ukraine Belarus Ivory Coast Accreditation Pakistan Myanmar
  • 18. www.bharatbiotech.com Products R&D Pipeline Projects Recognition Pipeline Products 1st Time in the world Typhoid Conjugate Vaccine S. No. Vaccines Product Development Preclinical Testing Phase I Phase II Phase III Commercial License 1 Chikungunya 2017 2 Malaria PvRII 2017 3 Staph Aureus MRSA 2018 4 Human Papilloma Virus 2018 5 Acellular Pertussis 2016 6 Tetanus (Meat Free) 2016 7 S. Paratyphi 2018 8 NTS Conjugates 2018 9 Sabin IPV 2018 Therapeutics Product Development Preclinical Testing Phase I Phase II Phase III Commercial License 1 THR-100 2015 2 Lysostaphin Topical 2015 3 Lysostaphin IV 2017 4 r Human Serum Albumin 2014 IssuesFast Facts
  • 21. www.bharatbiotech.com Recognition of Achievements Young Enterprising Company Products R&D Pipeline Projects RecognitionIssuesFast Facts VOA awards 2013 most promising vaccines for paediatric 16th March, 2013 Pharma Bio World Award Business Leader of the Year Biotechnology 2011 Best R&D Company of the year 2010 by Pharmaceutical Leadership Summit 2010 Mumbai National Technology Award Govt of India 2006 Business Innovation Marico Foundation & Business World 2006
  • 22. www.bharatbiotech.com Recognition of Achievements Young Enterprising Company Products R&D Pipeline Projects RecognitionIssuesFast Facts JRD TATA Best Entrepreneur award FICCI Award Excellence in Science Best Performance in Technology Marico Foundation Innovation Award TDB National award DBT-award for Product & Process
  • 23. www.bharatbiotech.com “Our mission is to address the health care needs of emerging markets, drive innovation, be a front runner in research and development of new vaccines and bio-therapeutics” Mission 7 Billion Dr. Krishna M. Ella Chairman & Managing Director
  • 24. www.bharatbiotech.com Thank You Address Products R&D Pipeline Projects RecognitionIssuesFast Facts Bharat Biotech International Limited Genome Valley, Shameerpet Mandal, Ranga Reddy District - 500 078 Andhra Pradesh, India. Tel.: +91 40 2348 0567 Fax: +91 40 2348 0560 info@bharatbiotech.com www.bharatbiotech.com